Latest / Parkinson's Disease Education Podcast

GLP-1 Agonists: A New Frontier in Parkinson's Treatment?
In this episode (watch here on YouTube), we dive into one of the most talked-about areas of emerging Parkinson's research: GLP-1 receptor agonists. Originally developed for diabetes and, more recently, widely used for weight management, GLP-1 medications like semaglutide and liraglutide are now being investigated for their potential neuroprotective effects.
We explore:
-What GLP-1 receptor agonists are and how they work
-Why these medications might have benefits beyond blood sugar control
-The current research examining GLP-1s in Parkinson's disease
-Possible mechanisms, including…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.